Jefferies Group LLC Dexcom Inc Call Options Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Sep 21, 2023	BUY	$129.87 - $162.82 $1.34 Million - $1.68 Million	10,300 Added 149.28%	17,200 $2.31 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $1.34 Million - $1.68 Million	10,300 Added 149.28%	17,200 $9.24 Million
Q4 2020 Sep 21, 2023	BUY	$78.0 - $104.5 $538,200 - $721,050	6,900 New	6,900 $637,000
Q4 2020 Feb 16, 2021	BUY	$78.0 - $104.5 $538,200 - $721,050	6,900 New	6,900 $2.55 Million
Q1 2020 May 15, 2020	SELL	$47.79 - $75.63 $812,430 - $1.29 Million	-17,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$35.53 - $43.8 $174,097 - $214,620	-4,900 Reduced 22.37%	17,000 $2.54 Million
Q3 2018 Nov 14, 2018	BUY	$23.35 - $36.72 $511,365 - $804,168	21,900 New	21,900 $3.13 Million

1,079

351M

8.45M

5.75M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $34.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.